CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Nieborowska-Skorska et al., have described elevated levels of superoxide in the CD34+CD38− CML precursor cells [11], thus establishing reactive oxygen signaling as a legitimate target in eliminating CML stem cells [7].